AXELAR

axelar-logo

Axelar AB is a Swedish biotechnology company that was founded in 2003 by Professor Magnus Axelson, Professor Olle Larsson and Karolinska Innovations AB/Karolinska Development AB. The company focuses its research and other activities on inhibitors of the insulin-like growth factor-1 (IGF-1) receptor and their applications in important human diseases, especially cancer. Axelar AB is situated in the Karolinska Institutet Science Park, Stockholm, Sweden.

#SimilarOrganizations #People #Website #More

AXELAR

Social Links:

Industry:
Biotechnology

Founded:
2003-01-01

Address:
Solna, Stockholms Lan, Sweden

Country:
Sweden

Website Url:
http://www.axelar.se

Status:
Active

Contact:
46-8-524-865-99

Email Addresses:
[email protected]

Technology used in webpage:
IPv6 Cloudflare Hosting Pound Sterling Japanese Yen Cloudflare DNS


Similar Organizations

arrowhead-pharmaceuticals-logo

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.

integral-molecular-logo

Integral Molecular

Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies

Current Employees Featured

not_available_image

Carl Harald Janson
Carl Harald Janson CEO @ Axelar
CEO

not_available_image

Magnus Axelsson
Magnus Axelsson Founder @ Axelar
Founder
2003-01-01

Founder


not_available_image

Magnus Axelsson

Official Site Inspections

http://www.axelar.se

  • Host name: 176.74.194.167
  • IP address: 176.74.194.167
  • Location: Sweden
  • Latitude: 59.3247
  • Longitude: 18.056
  • Timezone: Europe/Stockholm

Loading ...

More informations about "Axelar"

Axelar Foundation

Axelar is the programmable Web3 interoperability platform, connecting over 50 blockchains via a secure, scalable network โ€“ internet infrastructure for the worldโ€™s next super app. Via integrations ranging from Uniswap to Microsoft, Axelar โ€ฆSee details»

Axelar | The shortest path to scale

Axelar is the Web3 interoperability platform. An open stack to connect all blockchains. A single click to use and build everywhere.See details»

Axelar - Crunchbase Company Profile & Funding

Organization. Axelar . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... Contact Email [email protected]; Phone Number 46-8-524-865-99; Axelar AB is a โ€ฆSee details»

An Introduction to the Axelar Network | Axelar Blog

See details»

Axelar: universal blockchain interoperability | Axelar

Mar 8, 2022 Axelar is the universal overlay network, securely connecting all blockchain ecosystems to deliver Web 3 interoperability.See details»

Blockchain Interoperability Network Axelar Raises $35M at

Feb 15, 2022 Axelar, a decentralized network connecting multiple blockchains, has closed a $35 million Series B funding round at a $1 billion valuation. Investors included Polychain Capital โ€ฆSee details»

Axelar AB | Aktiebolag | Info & Löner - Bolagsfakta

Axelar AB โ€“ Org.nummer: 556623-6708. På Bolagsfakta.se hittar du kontakt-och företagsinformation, nyckeltal, lön till VD & styrelse m.m.See details»

Axelar Network - Crunchbase Investor Profile

Axelar is a cross-chain communication tool developing interoperability software to connect blockchain ecosystems, applications, and users. Axelar Network consists of a protocol suite, tools, and APIs, designed to break down the barriers to โ€ฆSee details»

Ripple and Axelar Foundation Partner to Enhance XRP โ€ฆ

Feb 27, 2024 Developed by Interop Labs, Axelar network integration with the XRPL will help enable secure and efficient transfer of assets across 55+ connected blockchains. Ripple and Axelar Foundation areโ€ฆSee details»

Axelar Documentation

Axelar delivers secure cross-chain communication for Web3, enabling you to build Interchain dApps that grow beyond a single chain. Secure means Axelar is built on proof-of-stake, the โ€ฆSee details»

What is Axelar and How Does it Work? - Gate.io

Jul 19, 2023 Explore Axelar, a revolutionary decentralized network that enhances blockchain interoperability. Its core elements include validators, smart contracts, developer tools, and the native AXL token, ensuring secure and โ€ฆSee details»

Axelar - Contacts, Employees, Board Members, Advisors & Alumni

Axelar AB is a Swedish biotechnology company that was founded in 2003 by Professor Magnus Axelson, Professor Olle Larsson and KarolinskaSee details»

Axelar AB - Cision News

About Axelar Axelar AB is a Swedish biotech company founded in 2003. The company is developing insulin-like growth factor-1 (IGF-1) receptor inhibitors for the treatment of cancer โ€ฆSee details»

A Technical Introduction to the Axelar Network - Medium

Jul 30, 2021 What is the Axelar network? Axelar network is a decentralized state machine responsible for facilitating cross-chain requests. The network supports a few key protocols, โ€ฆSee details»

Axelar price today, AXL to USD live price, marketcap and chart ...

Axelar claims to deliver โ€œsecure cross-chain communication for Web3.โ€ The project provides a decentralized network and tools to help builders of decentralized applications (dApps) with โ€ฆSee details»

Ripple and Axelar Join Forces: Unleashing XRPโ€™s Potential in DeFi

Key Takeaways: Axelar is leading the way in cross-chain interoperability, transforming how blockchain networks communicate. Ripple and Axelarโ€™s collaboration paves the way for XRP โ€ฆSee details»

Axelar - Overview, News & Similar companies | ZoomInfo.com

Jan 10, 2022 Axelar contact info: Phone number: +46 844683581 Website: www.axelar.se What does Axelar do? Axelar AB is a Swedish biotech company founded in 2003. The company is โ€ฆSee details»

Axelar Cryptocurrency Explained โ€“ Forbes Advisor Australia

Jul 23, 2024 Axelar has described itself as a โ€œpermissionless Stripe for Web3โ€. In the same way the fintech company Stripe simplifies payment processing across multiple online platforms, โ€ฆSee details»

Axelar AB - Cision News

Jun 2, 2019 About Axelar Axelar AB is a Swedish biotech company founded in 2003. The company is developing insulin-like growth factor-1 (IGF-1) receptor inhibitors for the treatment โ€ฆSee details»

www.exelar.com

Www.exelar.comSee details»

linkstock.net © 2022. All rights reserved